|
1
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qureshi 1A, Mattick JS and Mehler MF: Long
non-coding RNAs in nervous system function and disease. Brain Res.
1338:20–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dinger ME, Amaral PP, Mercer TR, Pang KC,
Bruce SJ, Gardiner BB, Askarian-Amiri ME, Ru K, Soldà G, Simons C,
et al: Long noncoding RNAs in mouse embryonic stem cell
pluripotency and differentiation. Genome Res. 18:1433–1445. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanduri C: Long noncoding RNA and
epigenomics. Adv Exp Med Biol. 722:174–195. 2015. View Article : Google Scholar
|
|
6
|
Yin DD, Zhang E B, You L H, Wang N, Wang
LT, Jin FY, Zhu YN, Cao LH, Yuan QX, De W and Tang W:
Down-regulation of lncRNA TUG1 affects apoptosis and insulin
secretion in mouse pancreatic β cells. Cell Physiol Biochem.
35:1892–1904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen J, Jia YS, Liu GZ, Sun Q, Zhang F, Ma
S and Wang YJ: Role of LncRNA TUG1 in intervertebral disc
degeneration and nucleus pulposus cells via regulating
Wnt/β-catenin signaling pathway. BiochemBiophys Res Commun.
491:668–674. 2017. View Article : Google Scholar
|
|
8
|
Michalik KM, You X, Manavski Y,
Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W,
Uchida S, et al: Long noncoding RNA MALAT1 regulates endothelial
cell function and vessel growth. Circ Res. 114:1389–1397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang M, Gu H, Xu W and Zhou X:
Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis
and improves left ventricular function in diabetic rats. Int J
Cardiol. 203:214–216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5:e15062014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tao H, Cao W, Yang JJ, Shi KH, Zhou X, Liu
LP and Li J: Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in
cardiac fibroblast proliferation and fibrosis. Cardiovasc Pathol.
25:381–389. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan JX: LncRNA H19 promotes
atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur
Rev Med Pharmacol Sci. 21:322–328. 2017.PubMed/NCBI
|
|
13
|
Ballantyne MD, Pinel K, Dakin R, Vesey AT,
Diver L, Mackenzie R, Garcia R, Welsh P, Sattar N, Hamilton G, et
al: Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates
Cell Proliferation. Circulation. 133:2050–2065. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu GZ, Tian W, Fu HT, Li CP and Liu B:
Long noncoding RNA-MEG3 is involved in diabetes mellitus-related
microvascular dysfunction. Biochem Biophys Res Commun. 471:135–141.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan S, Yang Z, Ke Z, Huang K, Liu N, Fang
X and Wang K: Down-regulation of the long non-coding RNA TUG1 is
associated with cell proliferation, migration, and invasion in
breast cancer. Biomed Pharmacother. 95:1636–1643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yun-Bo F, Xiao-Po L, Xiao-Li L, Guo-Long
C, Pei Z and Fa-Ming T: LncRNA TUG1 is up-regulated and promotes
cell proliferation in osteosarcoma. Open Med (Wars). 11:163–167.
2016.PubMed/NCBI
|
|
18
|
Rosner D, Mccarthy N and Bennett M:
Rapamycin inhibits human in stent restenosis vascular smooth muscle
cells independently of pRB phosphorylation and p53. Cardiovasc Res.
66:601–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kawatsu S, Oda KY, Tabata Y and Tabayashi
K: External application of rapamycin-eluting film at anastomotic
sites inhibits neointimal hyperplasia in a canine model. Ann Thorac
Surg. 84:560–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van der Heijden DJ, Westendorp IC,
Riezebos RK, Kiemeneij F, Slagboom T, van der Wieken LR and Laarman
GJ: Lack of efficacy of clopidogrel pre-treatment in the prevention
of myocardial damage after elective stent implantation. J Am Coll
Cardiol. 44:20–24. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matetzky S, Shenkman B, Guetta V, Shechter
M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D
and Hod H: Clopidogrel resistance is associated with increased risk
of recurrent atherothrombotic events in patients with acute
myocardial infarction. Circulation. 109:3171–3175. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gurbel PA, Bliden KP, Samara W, Yoho JA,
Hayes K, Fissha MZ and Tantry US: Clopidogrel effect on platelet
reactivity in patients with stent thrombosis: Results of the CREST
study. J Am Coll Cardiol. 46:1827–1832. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geisler T, Langer H, Wydymus M, Göhring K,
Zürn C, Bigalke B, Stellos K, May AE and Gawaz M: Low response to
clopidogrel is associated with cardiovascular outcome after
coronary stent implantation. Eur Heart J. 27:2420–2425. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moss SC, Lightell DJ Jr, Marx SO, Marks AR
and Woodset TC: Rapamycin Regulates Endothelial Cell Migration
through Regulation of the Cyclin-dependent Kinase Inhibitor
p27Kip1. J Biol Chem. 285:11991–11997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li E, Zhao Z, Ma B and Zhang J: Long
noncoding RNA HOTAIR promotes the proliferation and metastasis of
osteosarcoma cells through the AKT/mTOR signaling pathway. Exp Ther
Med. 14:5321–5328. 2017.PubMed/NCBI
|
|
26
|
Wang Y, Wang Y, Li J, Zhang Y, Yin H and
Han B: CRNDE, a long-noncoding RNA, promotes glioma cell growth and
invasion through mTOR signaling. Cancer Lett. 367:122–128. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matsumoto A, Pasut A, Matsumoto M,
Yamashita R, Fung J, Monteleone E, Saghatelian A, Nakayama KI,
Clohessy JG and Pandolfi PP: mTORC1 and muscle regeneration are
regulated by the LINC00961-encoded SPAR polypeptide. Nature.
541:228–232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muñoz-Chápuli R, Quesada AR and Medina
Angel M: Angiogenesis and signal transduction in endothelial cells.
Cell Mol Life Sci. 61:2224–2243. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lamalice L, Le Boeuf F and Huot J:
Endothelial cell migration during angiogenesis. Circ Res.
100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen
C, Cai Y, Huang H, Yang Y, Liu Y, et al: LincRNA-p21 Regulates
neointima formation, vascular smooth muscle cell proliferation,
apoptosis and atherosclerosis by enhancing p53 activity.
Circulation. 130:1452–1465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yan B, Yao J, Liu J Y, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Y, Ma G, Li C, Cao Z, Qie F and Xu
X: Baicaleininhibits VSMCs proliferation via regulating
LncRNAAK021954 gene expression. Int J Clin Exp Med. 8:22129–22138.
2015.PubMed/NCBI
|
|
34
|
Li J, Zhang M, An G and Ma Q: LncRNA TUG1
acts as a tumor suppressor in human glioma by promoting cell
apoptosis. Exp Biol Med (Maywood). 241:644–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu Y, Sun X, Mao C, Guo G, Ye S, Xu J, Zou
R, Chen J, Wang L, Duan P and Xue X: Upregulation of long noncoding
RNA TUG1 promotes cervical cancer cell proliferation and migration.
Cancer Med. 6:471–482. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao Z, Wang B, Hao J, Man W, Chang Y, Ma
S, Hu Y, Liu F and Yang J: Downregulation of the long non-coding
RNA taurine-upregulated gene 1 inhibits glioma cell proliferation
and invasion and promotes apoptosis. Oncol Lett. 15:4026–4032.
2018.PubMed/NCBI
|
|
37
|
Zhang M, Lu W, Huang YQ, Shi JZ, Wu X,
Zhang XL, Jiang RZ, Cai ZM and Wu S: Downregulation of the long
noncoding RNA TUG1 inhibits the proliferation, migration, invasion
and promotes apoptosis of renal cell carcinoma. J Mol Histol.
47:421–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han YH, Liu YC, Gui YT and Cai ZM: Long
intergenic non-coding RNA TUG1 is overexpressed in urothelial
carcinoma of the bladder. J Surg Oncol. 107:555–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cai H, Xue Y, Wang P, Wang Z, Li Z, Hu Y,
Li Z, Shang X and Liu Y: The long noncoding RNA TUG1 regulates
blood-tumor barrier permeability by targeting miR-144. Oncotarget.
6:19759–19779. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen C, Cheng GQ, Yang XN, Li CS, Shi R
and Zhao NN: Tanshinol suppresses endothelial cells apoptosis in
mice with atherosclerosis via lncRNA TUG1 up-regulating the
expression of miR-26a. Am J Transl Res. 8:2981–2991.
2016.PubMed/NCBI
|
|
41
|
Liu HT, Li F, Wang WY, Li XJ, Liu YM, Wang
RA, Guo WY and Wang HC: Rapamycin inhibits re-endothelialization
after percutaneous coronary intervention by impeding the
proliferation and migration of endothelial cells and inducing
apoptosis of endothelial progenitor cells. Tex Heart Inst J.
37:194–201. 2010.PubMed/NCBI
|
|
42
|
Wang Y, Chen J, Tang W, Zhang Y and Li X:
Rapamycin inhibits the proliferation of endothelial cells in
hemangioma by blocking the mTOR-FABP4 pathway. Biomed Pharmacother.
85:272–279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Medici D and Olsen BR: Rapamycin inhibits
proliferation of hemangioma endothelial cells by reducing
HIF-1-dependent expression of VEGF. PloS One. 7:e429132012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xue D, Zhou C, Lu H, Xu R, Xu X and He X:
LncRNA GAS5 inhibits proliferation and progression of prostate
cancer by targeting miR-103 through AKT/mTOR signaling pathway.
Tumor Biol. 37:1–11. 2016. View Article : Google Scholar
|
|
45
|
Malakar P, Shilo A, Mogilevsky A, Stein I,
Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV
and Karni R: Long Noncoding RNA MALAT1 promotes hepatocellular
carcinoma development by SRSF1 up-regulation and mTOR activation.
Cancer Res. 77:1155–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shui X, Zhou C, Lin W, Yu Y, Feng Y and
Kong J: Long non-coding RNA BCAR4 promotes chondrosarcoma cell
proliferation and migration through activation of mTOR signaling
pathway. Exp Biol Med (Maywood). 242:1044–1050. 2017. View Article : Google Scholar : PubMed/NCBI
|
